Zevra Therapeutics, Inc.
ZVRA
$11.05
$0.252.32%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.03% | -4.26% | -1.53% | 223.50% | -9.88% |
| Total Receivables | -4.99% | 38.10% | -7.80% | 44.77% | 20.06% |
| Inventory | 32.76% | 27.29% | 23.38% | -56.70% | 29.90% |
| Prepaid Expenses | -29.35% | -5.41% | 69.99% | 15.56% | -7.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.12% | -0.94% | -0.54% | 177.47% | -5.18% |
|
|
|||||
| Total Current Assets | 3.12% | -0.94% | -0.54% | 177.47% | -5.18% |
| Net Property, Plant & Equipment | -10.82% | -6.79% | -12.89% | 1.80% | 103.16% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.92% | -4.69% | -4.48% | -89.53% | -2.34% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -86.01% | 17.07% | -12.87% | -90.81% | -4.17% |
| Total Assets | -2.16% | 5.41% | 5.40% | 48.39% | -3.04% |
|
|
|||||
| Total Accounts Payable | 371.67% | -77.62% | -30.11% | -11.09% | 36.28% |
| Total Accrued Expenses | -38.18% | 279.89% | 0.18% | 8.36% | -71.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.10% | -4.99% | -16.00% | -10.87% | 40.24% |
| Total Finance Division Other Current Liabilities | 44.39% | 67.65% | 30.94% | 101.88% | 50.49% |
| Total Other Current Liabilities | 44.39% | 67.65% | 30.94% | 101.88% | 50.49% |
| Total Current Liabilities | 19.73% | 50.42% | -9.43% | 6.88% | -20.81% |
|
|
|||||
| Total Current Liabilities | 19.73% | 50.42% | -9.43% | 6.88% | -20.81% |
| Long-Term Debt | -- | 1.01% | 1.02% | 1.00% | 0.98% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.74% | -11.08% | -8.78% | -8.55% | 211.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.72% | -42.32% | 0.20% | 11.51% | -2.38% |
| Total Liabilities | -44.05% | -5.02% | -1.51% | 5.59% | -4.89% |
|
|
|||||
| Common Stock & APIC | 2.43% | 1.32% | 2.92% | 0.69% | 0.93% |
| Retained Earnings | 8.98% | 2.80% | -0.13% | 14.69% | -0.61% |
| Treasury Stock & Other | -8.79% | 12.33% | 0.09% | -21.20% | -6.89% |
| Total Common Equity | 33.07% | 16.14% | 13.59% | 185.77% | 3.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.07% | 16.14% | 13.59% | 185.77% | 3.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.07% | 16.14% | 13.59% | 185.77% | 3.42% |
|
|
|||||